Table 2.
Leclercia adecarboxylata isolates.
| Antibiotics Tested | Susceptible Isolates (%) | |
|---|---|---|
| Penicillins | Ampicillin | 8/8 (100) |
| Amoxicillin/clavulanic acid | 8/8 (100) | |
| Ticarcillin/clavulanic acid | 5/5 (100) | |
| Piperacillin/tazobactam | 8/8 (100) | |
| Cephalosporins | Cefazolin | 3/3 (100) |
| Cefoxitin | 6/6 (100) | |
| Ceftriaxone | 8/8 (100) | |
| Cefotaxime | 8/8 (100) | |
| Ceftazidime | 8/8 (100) | |
| Cefepime | 8/8 (100) | |
| Carbapenems | Imipenem | 8/8 (100) |
| Ertapenem | 8/8 (100) | |
| Aminoglycosides | Amikacin | 8/8 (100) |
| Gentamicin | 3/3 (100) | |
| Tobramycin | 1/1 (100) | |
| Fluoroquinolones | Nalidix acid | 3/3 (100) |
| Norfloxacin | 5/5 (100) | |
| Ofloxacin | 2/2 (100) | |
| Ciprofloxacin | 6/6 (100) | |
| Folate synthesis inhibitors | Trimethoprim/sulfamethoxazole | 3/3 (100) |
| Nitrofurans | Nitrofurantoin | 2/2 (100) |
| Phosphonic acid | Fosfomycin | 1/2 (50) |
Not all isolates were tested for all drugs listed. Minimum inhibitory concentration values are not available as disk diffusion testing was employed for susceptibility testing.